Apyx Medical Corporation (APYX)

Market Cap	159.37M +205.3%
Revenue (ttm)	52.84M +9.9%
Net Income	-11.21M
EPS	-0.27
Shares Out	41.83M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	124,476
Open	3.850
Previous Close	3.750
Day's Range	3.750 - 3.990
52-Week Range	0.825 - 4.500
Beta	1.54
Analysts	Strong Buy
Price Target	6.50 (+70.6%)
Earnings Date	May 7, 2026

About APYX

Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Surgical Aesthetics and Original Equipment Manufacturing (OEM). It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures; and a portfolio of single-use handpieces and accessories for open and laparo...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Jan 1, 1987
• Employees: 205
• Stock Exchange: NASDAQ
• Ticker Symbol: APYX
• Website: https://apyxmedical.com

Financial Performance

In 2025, Apyx Medical's revenue was $52.84 million, an increase of 9.86% compared to the previous year's $48.10 million. Losses were -$11.21 million, -52.22% less than in 2024.

Analyst Summary

According to 4 analysts, the average rating for APYX stock is "Strong Buy." The 12-month stock price target is $6.5, which is an increase of 70.60% from the latest price.

Price Target

$6.5

(70.60% upside)

Analyst Consensus: Strong Buy